AK2 in Neutrophil Differentiation by Tanimura, Ayako et al.
Differential Expression of Adenine Nucleotide
Converting Enzymes in Mitochondrial Intermembrane
Space: A Potential Role of Adenylate Kinase Isozyme 2 in
Neutrophil Differentiation
Ayako Tanimura, Taigo Horiguchi, Keiko Miyoshi, Hiroko Hagita, Takafumi Noma*
Department of Molecular Biology, Institute of Health Biosciences, the University of Tokushima Graduate School, Tokushima, Japan
Abstract
Adenine nucleotide dynamics in the mitochondrial intermembrane space (IMS) play a key role in oxidative phosphorylation.
In a previous study, Drosophila adenylate kinase isozyme 2 (Dak2) knockout was reported to cause developmental lethality at
the larval stage in Drosophila melanogaster. In addition, two other studies reported that AK2 is a responsible gene for
reticular dysgenesis (RD), a human disease that is characterized by severe combined immunodeficiency and deafness.
Therefore, mitochondrial AK2 may play an important role in hematopoietic differentiation and ontogenesis. Three additional
adenine nucleotide metabolizing enzymes, including mitochondrial creatine kinases (CKMT1 and CKMT2) and nucleoside
diphosphate kinase isoform D (NDPK-D), have been found in IMS. Although these kinases generate ADP for ATP synthesis,
their involvement in RD remains unclear and still an open question. In this study, mRNA and protein expressions of these
mitochondrial kinases were firstly examined in mouse ES cells, day 8 embryos, and 7-week-old adult mice. It was found that
their expressions are spatiotemporally regulated, and Ak2 is exclusively expressed in bone marrow, which is a major
hematopoietic tissue in adults. In subsequent experiments, we identified increased expression of both AK2 and CKMT1
during macrophage differentiation and exclusive production of AK2 during neutrophil differentiation using HL-60 cells as an
in vitro model of hematopoietic differentiation. Furthermore, AK2 knockdown specifically inhibited neutrophil differentiation
without affecting macrophage differentiation. These data suggest that AK2 is indispensable for neutrophil differentiation
and indicate a possible causative link between AK2 deficiency and neutropenia in RD.
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Introduction
Adenine nucleotides such as ATP, ADP, and AMP are involved
in several cellular functions, including intracellular and extracel-
lular signaling, energy metabolism, cell growth, and differentiation
[1], [2]. Among these processes, energy metabolism is critical for
cell viability and homeostasis. In mammalian systems, cells
produce ATP through cytosolic glycolysis and mitochondrial
oxidative phosphorylation depending on O2 availability. In
somatic cells, ATP is efficiently produced by coupling respiratory
chain and ATP synthase under aerobic condition [3]. Although 36
moles of ATP are produced from 1 mole of glucose in
mitochondria, only 2 moles are produced in cytosol through
glycolysis. Therefore, mitochondrial activity is a great advantage
for differentiated somatic cell functions and homeostasis. High-
energy phosphoryl transfer between ATP-generating and ATP-
consuming sites is primarily mediated by creatine kinases (CK; EC
2.7.3.2) and adenylate kinases (AK; EC 2.7.4.3) [1], [2], [4], [5].
During active mitochondrial respiration, ADP transfer into the
mitochondrial matrix is mediated by the adenine nucleotide
translocator (ANT), which is located in IMS [6]. ADP in IMS is
then rapidly exchanged with ATP by mitochondrial CK and/or
AK. Thereby, CK and AK systems contribute to coordinated
energy transfer and feedback signal transduction networks [7],
ensuring rapid recycling of ADP for efficient mitochondrial ATP
production [8], [9].
The AK family comprises nine isozymes that are located in
various subcellular compartments and are distributed in tissues as
follows: AK1, 5, 7, and 8 are located in the cytosol, AK2, 3, and 4
are located in the mitochondria, and AK6 is located in the nucleus
[1], [2], [10]–[12]. In addition, a recent study using GFP-fusion
proteins demonstrated AK9 in both cytosolic and nuclear
compartments [13]. Cytosolic and organellar AK isozymes
maintain adenine nucleotide homeostasis via the reaction; Mg2+-
ATP (or GTP) + AMP « Mg2+-ADP (or GDP) + ADP. Although
AK3 and 4 are located in the mitochondrial matrix, AK2 is
uniquely located in IMS, particularly in liver and kidney tissues
[10], [14]. As a member of the family of ATP-AMP phospho-
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transferases, AK2 catalyzes the reversible transfer of a phosphoryl
group between ATP + AMP and 2 ADP [1], [10]. Other kinases in
IMS include creatine kinases CKMT1 and CKMT2 and
nucleoside diphosphate kinase D (NDPK-D; EC 2.7.4.6). CKMT1
is expressed in most tissues, except muscle and liver, whereas
sarcomeric CKMT2 is located primarily in muscle and heart
tissues. Both CKMT1 and CKMT2 catalyze the reversible
reaction ATP + creatine « ADP + phosphocreatine [5], [15],
whereas NDPK-D (also known as NME-4, NM23-H4) catalyzes
the reaction ATP + GDP « ADP + GTP [16].
In our previous study, we reported developmental failure in
Dak2 knockout Drosophila melanogaster, showing that Dak2 knockout
is lethal prior to the third larval stage [17]. Additionally, ak2
knockdown of lepidopteran insects Helicoverpa armigera has reported
larval growth impairment and reduction of haemocytes [18].
Furthermore, two groups independently reported that AK2 is a
responsible gene for RD [19], [20], and soon after another group
reported that Ak2 knockdown caused impaired cellular differen-
tiation in both adipose cells and B cells [21]. In addition, recent
our study demonstrated that any germ-layer specific knockdown of
Dak2 gene by RNAi treatment resulted in larval lethality, showing
that ak2 is definitively required for larval developmental process of
D. melanogaster [22]. RD is a type of severe combined immuno-
deficiency caused by impairment of lymphoid and neutrophil
lineage development but does not involve erythroid, platelet, or
macrophage lineages. Based on these findings, we hypothesized
that AK2 deficiency may inhibit neutrophil differentiation through
impaired ADP recycle across the mitochondrial innermembrane,
and it may lead to both dysfunction of mitochondrial energy
metabolism and impairment of lymphocytic and granulocytic
cellular differentiation, as observed in patients with RD.
To test these hypotheses, we investigated the expression of
mitochondrial kinases. Then, we analyzed the relationship
between their expressions and myelocytic differentiation using
hematopoietic HL-60 cells [23], [24].
Materials and Methods
Cells culture and reagents
Mouse embryonic stem cells, B6J-S1UTR, and HL-60 human
promyelocytic leukemia cells were provided by the RIKEN Bio
Resource Center through the National Bio-Resource Project of the
Ministry of Education, Culture, Sports, Science and Technology,
Japan [25], [26]. ES cells were cultured in an ES medium on
mitomycin C-treated MEF feeder cells (MEF-MMC; Repro
CELLS, Yokohama, Japan). ES medium comprised high-glucose
DMEM containing 20% KSR (Gibco, Life technologies, Carlsbad,
CA), 0.1 mM NEAA (Gibco), 1000 U/ml mouse LIF (Chemicon
International, Inc., Temecula, CA), and 0.1 mM 2-ME (Sigma, St.
Louis, MO). ES cells were harvested after removing MEF-MMC
cells by trypsinization. HL-60 cells were maintained in a RPMI-
1640 medium with 10% fetal bovine serum (FBS).
Animals
All animal experiments were approved by the Ethics Committee
for Animal Experiments of the University of Tokushima
(No. 11115). In addition, experiments were performed according
to the guidelines and principles for the care and use of animals at the
University of Tokushima. All surgery was performed under ether
anesthesia, and all efforts were made to minimize suffering. Seven-
week-old male and pregnant ICR mice were purchased from Japan
SLC (Shizuoka, Japan). Brain, heart, lung, stomach, large intestine,
liver, kidney, thymus, spleen, bone marrow, muscle, and testis
tissues were collected from anesthetized 7-week-old mice. At day 8
of gestation, pregnant mice were anesthetized, and embryo propers
were carefully removed from extra-embryonic portion, such as yolk
sac following laparotomy. Then, we used only embryo proper that
will become a mouse body, not extra-embryonic portion for the
analyses. Hereafter, embryo propers are referred to as ‘‘embryos’’.
ES cells, embryos, and tissues were homogenized in a lysis buffer
containing 60-mM Tris-HCl, (pH 7.5), 150 mM NaCl, 5 mM
EDTA, and 0.2% TritonX-100 and were then sonicated. After
centrifuging at 5000 rpm for 5 min at 4uC, supernatants were
collected for experiments.
RT-PCR
Total RNA was extracted from mouse ES cells, embryos, and
adult tissues using the TRI Reagent (Molecular Research Center,
Cincinnati, OH) according to the product manual. After DNase I
treatment, cDNA was synthesized from 1 mg of total RNA using
the TaKaRa DNA PCR Kit (AMV) (TaKaRa, Kyoto, Japan).
PCR reactions were performed using Go Taq Flexi DNA
polymerase (Promega, Madison, WI) and following specific primer
pairs: Ak2 forward 59-CCCAAACTGGCTGAAAAC-39, reverse
59-TCGCAAACACGATGTCAG-39; Ckmt1 forward 59-TTCT-
CCCGTCTGCTGTCTG-39, reverse 59-TGGACAGGTCAA-
GATGTAGCC-39; Ckmt2 forward 59-CAAGAAGAAGGATG-
GCCAGT-39, reverse 59-TTCATCACCCTAGGGTCATA-39;
Ndpk-d forward 59- ATGGCTCTCAGAGTCCTTCTGTTAA-
39, reverse 59-CATCAAAGAGAACAAGGTTTTGGAC-39; 18S
rRNA forward 59-TACCTGGTTGATCCTGCCAGTAGGAT-
39, reverse 59-CCCGTCGGCATGTATTAGCTCTAGAA-39.
Following agarose gel electrophoresis, PCR products were
quantitated using densitometry with a Bio-Rad ChemiDoc XRS
system (Bio-Rad, Hercules, CA).
Western blot
Western blot analyses were performed as previously described
[27]. Briefly, 20 mg of total protein were loaded into 10% or
12.5% SDS-polyacrylamide gels, and electrophoresis was per-
formed. After transfer of proteins to PVDF membranes and
nonspecific epitope blocking, the following antibodies were used
for immunodetection; anti-AK2 antibody [28], anti-AK2 (H-65)
(Santa Cruz, Santa Cruz, CA), anti-uMtCK (N-15) (Santa Cruz),
anti-CKMT2 (Abcam, Cambridge, MA), anti-nm23-H4 (H-53)
(Santa Cruz), anti-GAPDH (14C10) (Cell signaling, Danvers,
MA), monoclonal anti-b-actin Clone AC-15 (Sigma), human
integrin alpha M/CD11b (238439) (R & D systems, Minneapolis,
MN), Pan-Actin (Cell signaling), antigoat HRP IgG (Dako,
Glostrup, Denmark), ECL antirabbit IgG horseradish peroxi-
dase-linked whole antibody, and antimouse IgG (GE Healthcare,
Munich, Germany). Signals were detected using the Immobilon
Western Chemiluminescent HRP Substrate (Millipore, Billerica,
MA) and Fuji medical X-ray film (Fujifilm, Tokyo, Japan).
Enzyme assay
Enzyme assays were performed according to our previous
report [14]. Briefly, AK1 and AK2 activities were assayed in the
reaction: ATP + AMP « 2 ADP. ADP formation was coupled
with pyruvate kinase and lactate dehydrogenase reactions, leading
to NADH oxidation. Subsequently, AK reaction rates were
determined by measuring the decrease in NADH absorbance at
340 nm at 25uC. One unit of AK activity was defined as that
required to produce 1 mmol of ADP per min at 25uC. AK2 activity
was defined as total AK activity remaining after N-ethylmaleimide
(AK1 inhibitor) treatment [29], and AK1 activity was determined
by subtracting AK2 activity from total AK activity.
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Macrophage- and neutrophil differentiation from HL-60
cells
Neutrophil differentiation was induced by treating HL-60 cells
(2.56105 cells/ml) with 10 mM all-trans retinoic acid (ATRA;
Sigma) [23]. Macrophage differentiation was induced by treating
HL-60 cells (16105 cells/ml) with 200 ng/ml phorbol myristate
acetate (PMA; Sigma) [24].
Cytological staining
Macrophage- and neutrophil-differentiated HL-60 cells were
analyzed by staining with Giemsa and Wright-Giemsa solution
(Muto Pure Chemicals, Tokyo, Japan), respectively, according to
the manufacturer’s protocol. Briefly, cells were dried for 1–3 min
and were fixed in methanol for 30 s. Subsequently, macrophages
were stained with Giemsa solution for 10 min and were then
washed in water. Further, neutrophils were stained with Wright-
Giemsa solution for 2 min. After diluting M/150 phosphate
buffer, cells were stained for 8 min and were then washed.
AK2 knockdown
AK2 knockdown was achieved by transfection using Silencer
Select validated AK2 siRNA (S1211, Ambion, Life technologies,
Carlsbad, CA) and a Nucleofector II Cell Line Nucleofector Kit V
(Lonza Japan, Tokyo). Before nucleofection, cells were seeded at
16105 cells/ml. After 3 days, 26106 cells were collected and
nucleofected using program T-019 with 100 ml nucleofector solution
and 6 or 9 mg AK2 siRNA, or 9 mg of Silencer Select Negative
Control #1 (Ambion) according to manufacturer’s instructions. For
differentiation experiments, cells were treated with differentiation-
inducing reagents (ATRA and PMA) for 2 days after nucleofection.
NBT assay
Differentiated cells (1.26106 cells) were incubated with NBT
solution (Muto Pure Chemicals, Tokyo, Japan) as previously
described [23], [25], [30]. Then, the cells were suspended in PBS,
and NBT-positive cells (more than 200 cells) were counted and
calculated the ratio of NBT positive cells.
ROS measurement
ROS levels in AK2-knockdown HL-60 cells were measured
during differentiation by CellROX Green Oxidative Stress
Reagents (Life Technologies) according to the manufacturer’s
instruction. Briefly, the differentiated cells at appropriate time
points were incubated with 10 mM CellROX reagent for 30min at
37uC. The cells were washed twice with PBS and measured
fluorescent intensity using Varioskan Flash microplate reader
(Thermo Scientific, MA, USA).
Statistics
Each analysis was performed more than three independent
materials and experiments conducted under the same experimental
conditions. The image data of RT-PCR and WB were quantified
using Image J software (http://rsb.info.nih.gov/ij/). The data was
normalized against 18S rRNA, Pan-Actin, or protein staining density
by Coomassie Brilliant Blue or Ponceau S, and calculated the means 6
S.E., respectively. Student’s t-test was performed with Microsoft Excel.
Results
Expression of mitochondrial kinases in adult mouse
tissues
Initially, we investigated expressions of Ak2, Ckmt1, Ckmt2, and
Ndpk-d mRNA in adult mouse tissues. As presented in Figure 1A,
Ak2 mRNA was detected in all 12 mouse tissues, including brain,
heart, lung, stomach, large intestine, liver, kidney, thymus, spleen,
bone marrow, skeletal muscle, and testis. We next examined
mRNA expression of each Ak2 isoform since two Ak2 isoforms,
Ak2A and Ak2B, have been previously reported (NM_001033966.4
and NM_016895.4) [31], [32] (Figure S1A). In adult mouse
tissues, we found differential expression pattern of Ak2A and Ak2B,
indicating that expression of Ak2 isoforms could be regulated by
alternative splicing in a tissue-specific manner (Figure S1B).
On the other hand, Ckmt1 mRNA expression was detected in
brain, lung, stomach, large intestine, and thymus, and not in bone
marrow and testis. In addition, Ckmt2 mRNA was highly expressed
in heart and skeletal muscle, whereas Ndpk-d mRNA was
ubiquitously expressed, although at low levels in brain and skeletal
muscle.
Western blot analyses detected strong Ak2 signals in most
tissues, except brain, lung, and skeletal muscle, with strongest
signals in liver and kidney tissues (Figure 1B). Ckmt1 was strongly
detected in brain, heart, stomach, and large intestine, but not in
spleen, bone marrow, and testis. Strong Ckmt2 signals were
detected in both heart and skeletal muscle. Ndpk-d was detected in
almost all tissues but at very low levels in bone marrow. Figure 1C
shows the relative levels of mRNA and protein expression. Ak2
protein expression was roughly correlated with mRNA expression
in each tissue, whereas mRNA and protein expression of Ckmt1
and Ckmt2 were varied among tissues, suggesting that the
expression of CK isozymes is tissue-specifically and post-
transcriptionally regulated. In bone marrow, mRNA and proteins
of Ckmt1 and Ckmt2 were not detected, and Ndpk-d expression
was also very low, suggesting that Ak2 may play an exclusive role
in adenine nucleotide metabolism of bone marrow.
Expression of mitochondrial kinases in mouse ES cells
and E8 embryos
During differentiation from mouse ES cells to each tissue,
knockdown of AK isoforms, AK1, 2 and 5, in stem cells interfered
with mitochondrial network formation and cardiac differentiation
[33]. To further examine developmental regulation of adenine
nucleotide metabolizing enzymes, we analyzed mRNA and
protein expressions of Ak2, Ckmt1, Ckmt2, and Ndpk-d in two
developmental stages of mouse ES cells and E8 embryos. As shown
in Figure 2A, Ak2 and Ckmt1 mRNA were detected in mouse ES
cells, whereas Ckmt2 was not observed. In contrast, Ak2 mRNA
was similarly detected in E8 embryos, whereas both Ckmt1 and
Ckmt2 mRNA were barely detected. Ndpk-d mRNA was weakly
observed in both ES cells and E8 embryos. In addition, transcripts
of both Ak2 isoforms were detected in ES cells and E8 embryos
(Figure S1C).
By western blot analysis, Ak2 protein was detected in both
mouse ES cells and E8 embryos (Figure 2B), and Ndpk-d protein
expression was slightly increased along development as shown in
ES cells and E8 embryos. In contrast, both Ckmt1 mRNA and
protein were detected in ES cells. These results demonstrated that
expression of mitochondrial kinases are stage-specifically regulated
during early embryonic stages (Figure 2C).
AK2 Enzyme Activity in Mouse ES Cells, Embryos, and
Adult Tissues
AK activities were measured in mouse ES cells, E8 embryos,
and all 12 adult tissues. AK2 activities in adult tissues were roughly
correlated with the levels of Ak2 protein expression, showing high
in heart, liver, and kidney (Figure 3A). In contrast, AK1 activity
was much higher in heart and skeletal muscle than in other tissues.
AK2 in Neutrophil Differentiation
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However, AK2 activity without AK1 activity was uniquely
detected in spleen, thymus, bone marrow, and liver. Moreover,
relatively high AK2 activities were detected in mouse ES cells and
embryos, whereas AK1 activity was very low in them (Figure 3B).
Finally, AK2 activity in ES cells was higher compared with that in
embryos, consistent with the level of Ak2 protein expression,
suggesting that Ak2 may play a distinct role in IMS during early
embryonic stages.
Figure 1. Expression of mitochondrial kinases in 7-week-old ICR mouse tissues. (A) Tissue-specific expression of Ak2, Ckmt1, Ckmt2, and
Ndpk-d mRNA in adult mouse tissues. Br, brain; He, Heart; Lu, lung; St, stomach; LI, large intestine; Li, liver; Ki, kidney; Th, thymus; Sp, spleen; BM, bone
marrow. Mu, skeletal muscle; Te, testis; 18S rRNA is presented as a loading control. Sizes of PCR products are presented on the right side of the panel.
(B) Tissue-specific expression of Ak2, Ckmt1, Ckmt2, and Ndpk-d proteins in adult mouse tissues. b-Actin and Gapdh are presented as loading
controls. Molecular weight is shown on the right side of the panel. (C) Relative levels of mRNA and protein expression of each enzyme in adult mouse
tissues. The relative level is shown compared to the value of heart as 1. Sample numbers are shown as follows; N = 4 for Ak2 and Ndpk-d, N = 5 for
Ckmt1, Ckmt2, Ak2, Ckmt1, Ckmt2 and Ndpk-d.
doi:10.1371/journal.pone.0089916.g001
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Expression of mitochondrial kinases during HL-60
myelocytic differentiation
Exclusive expression of AK2 in bone marrow suggests a causal
connection between AK2 deficiency and RD phenotypes. Bone
marrow contains hematopoietic precursor cells and common
myeloid progenitor (CMP) cells that differentiate into neutrophils
and monocytes/macrophages [34], [35]. Therefore, mitochondrial
kinases may be differentially regulated during terminal differen-
tiation from CMP to neutrophil or monocyte/macrophage
lineages. In order to examine the expression profile of each
kinase, we used ATRA- and PMA-treated HL-60 cells as an in vitro
model of terminal differentiation to granulocytes and monocytes/
macrophages [23], [24].
Differentiation of HL-60 cells into monocytes/macrophages was
induced after 1 day PMA treatment, as indicated by attachment of
cells to culture dishes. The neutrophil differentiation of HL-60
cells was induced by 10 mM ATRA treatment for 4 days and was
recognized by morphologically segmented nuclei (Figure 4A).
After confirming morphology, we analyzed expression patterns of
AK2, CKMT1, CKMT2, and NDPK-D during macrophage- and
neutrophil differentiation. AK2 signals were increased in a dose-
dependent manner during macrophage differentiation. CKMT1
expression, which was not detected on day 0, was weakly induced
over the course of macrophage differentiation (Figure 4B), whereas
CKMT2 remained undetectable. In contrast, constant AK2
expression was detected during neutrophil differentiation from
days 0 to 4, whereas CKMT1 and CKMT2 remained undetect-
able throughout the time course (Figure 4C). In both differenti-
ations, significant induction of the myeloid differentiation marker
CD11b was confirmed in both macrophage- and neutrophil
differentiation. Interestingly, NDPK-D signals were decreased
during differentiation, suggesting that NDPK-D does not play an
Figure 2. Expression of mitochondrial kinases in mouse ES cells and embryos. (A) RT-PCR analyses were performed on mouse ES cells and
E8 embryos. ES, mouse ES cells; E8, mouse E8 embryos. Br, brain; Ki, kidney; and He, heart tissues were used as PCR controls. 18S rRNA is presented as
a loading control. Sizes of PCR products are presented on the right side of the panel. (B) Western blot analysis was performed on mouse ES cells and
E8 embryos. Pan-Actin antibody is used as a control. Molecular weight is shown on the right side of the panel. (C) Relative mRNA and protein
expression values of each enzyme in mouse ES cells and E8 embryos. ES mRNA and all protein data, N = 3; E8 mRNA, N = 5.
doi:10.1371/journal.pone.0089916.g002
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important role in adenine nucleotide metabolism in IMS during
macrophage- and neutrophil differentiation. We further examined
AK2A and AK2B mRNA expressions in human HL-60 cells during
macrophage- and neutrophil differentiations. The similar levels of
both AK2 transcripts were detected in HL-60 cells during
macrophage- and neutrophil differentiation, indicating that the
alternative splicing of AK2 isoforms is not affected by myeloid
differentiation, at least, in our samples examined (Figure S1D).
Effects of AK2 knockdown on macrophage- and
neutrophil differentiation
To further clarify the role of AK2 in macrophage- and
neutrophil differentiation, we performed AK2 knockdown exper-
iments in HL-60 differentiation model (Figure 5A). CD11b
expression in macrophage-differentiating HL-60 cells was imper-
vious to AK2 and control siRNAs. Functional maturity of
differentiated myeloid cells was assessed according to the
phagocytic reduction of the NBT dye. Furthermore, differentiation
rates were assessed by counting NBT-positive cells with phagocytic
and reducing activity. Interestingly, the number of NBT-positive
cells was not affected by AK2 knockdown (Figure 5B, left panel),
indicating that AK2 does not play a critical role in the macrophage
differentiation of HL-60 cells. In addition, AK2 knockdown had no
effect on CKMT1 expression (Figure 5A, upper panel).
On the other hand, CD11b expression was decreased by AK2
knockdown in a dose-dependent manner during neutrophil
differentiation (Figure 5A, lower panel). Furthermore, the NBT
assay revealed significant reductions in neutrophil differentiation
rates caused by AK2 knockdown (Figure 5B, right panel).
In addition, we further examined ROS production and ATP
levels in AK2 knockdown during myelocytic differentiation, since
enhanced ROS production was demonstrated in fibroblasts of
individuals with RD [19]. We found that ROS level was
specifically increased in AK2-knockdown HL-60 cells at day 4 of
ATRA treatment compared with control, but not in PMA-treated
HL-60 (Figure 5C), suggesting that neutrophil differentiation
promotes ROS-induced damage under the condition of AK2
deficiency. On the other hand, ATP levels were reduced by AK2-
knockdown treatment and maintained at the similar level during
both macrophage- and neutrophil differentiation (Figure S2).
These results indicated that AK2 among the mitochondrial kinases
may play a major role in mitochondria during neutrophil
differentiation.
Discussion
Previous studies have demonstrated that AK2 deficiency
impairs ontogenesis and cellular differentiation [17], [19]–[22],
suggesting that ADP recycling by AK2 in IMS is essential for these
processes. However, roles of the three other mitochondrial kinases
such as CKMT1, CKMT2 and NDPK-D in the development of
RD phenotypes remain unclear and still an open question. These
kinases catalyze the formation of ADP, which functions as a
substrate for ATP synthase [1], [2], [5], [9], [16], [36], [37]. To
clarify the roles of AK2 and other mitochondrial kinases in
hematopoietic differentiation, we determined the expression
patterns and functions of them in both mouse tissues and cultured
cells.
Expression patterns of mitochondrial kinases
Expression profiles of Ak2, Ckmt1, Ckmt2 and Ndpk-d revealed
tissue-specific and developmental stage-specific regulation, as
shown in Figures 1 and 2, respectively. As previously demonstrated
[14], high AK2 activities were detected in liver, kidney and heart
tissues of mice (Figure 3). However, Ndpk-d protein levels did not
change during development and were observed in all tissues,
except bone marrow, suggesting that Ndpk-d may have house-
keeping rather than developmental roles. In contrast, Ckmt1 and
Ckmt2 were highly expressed in brain, heart, stomach, large
intestine and skeletal muscle, thereby indicating that tissue-specific
expression of mitochondrial enzymes individually or cooperatively
contributes toward adenine nucleotide homeostasis. In this study,
we found that the combinatory expression patterns of mitochon-
drial kinase are varied in each tissue. In particular, Ak2 is
exclusively expressed in bone marrow, suggesting a unique role of
AK2 in ADP recycling in IMS.
We also analyzed the developmental regulation of the
mitochondrial kinases, Ak2, Ckmt1 and Ndpk-d, which were all
expressed in mouse ES cells. Subsequently, Ak2 and Ndpk-d were
dominantly expressed in E8 embryos, whereas AK2 activity was
reduced by half in ES cells. Nevertheless, AK2 activity may not be
critical in mammalian embryonic development as observed in D.
melanogaster [17]. In fact, RD patients with AK2 mutations were
safely born [19], [20], possibly because of compensatory mech-
anism including glycolytic bioenergetics.
Role of AK2 in hematopoietic differentiation
The expression analyses reveal high Ak2 expression in
hematopoietic bone marrow tissue, suggesting an important role
of AK2 in hematopoiesis. Accordingly, we characterized effects of
AK2 knockdown on myelocytic differentiation using human
bipotent hematopoietic HL-60 cells as an in vitro model [23], [24].
Expression of mitochondrial kinases was uniquely observed
during myelocytic differentiation, with gradually increased AK2
Figure 3. AK activity in mouse ES cells, E8 embryos, and 7-
week-old adult mouse tissues. (A) AK1 and AK2 activities in adult
mouse tissues; (B) AK1 and AK2 activities in mouse ES cells and E8
embryos. The activity of each AK was normalized to total protein
contents. Open and closed bars indicate AK1 and AK2 activity,
respectively. Br, brain; He, Heart; Lu, lung; St, stomach; LI, large
intestine; Li, liver; Ki, kidney; Th, thymus; Sp, spleen; BM, bone marrow;
Mu, skeletal muscle; and Te, testis. N = 3. *, p,0.05.
doi:10.1371/journal.pone.0089916.g003
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and CKMT1 expression during macrophage differentiation
(Figure 4B). In contrast, AK2 was dominantly and constantly
expressed compared with other enzymes during neutrophil
differentiation (Figure 4C). According to these findings and
previous reports [19], [20], we examined whether AK2 deficiency
disturbs neutrophil differentiation leading to neutropenia. In these
experiments, we found that AK2 knockdown particularly inhibited
neutrophil differentiation, but not macrophage, (Figure 5), indi-
cating a cell-type specific role of AK2 during myeloid differenti-
ation.
Based on these findings, we propose the following working
hypothesis for the molecular basis of RD (Figure 6). Loss of
Figure 4. Regulation of mitochondrial kinase expression during HL-60 cell differentiation into macrophages or neutrophils. (A)
Morphological confirmation of macrophage- and neutrophil differentiation of HL-60 cells. HL-60 cells were treated with 20 nM PMA for macrophage
differentiation or 10 mM ATRA for neutrophil differentiation. PMA-treated HL-60 cells were stained with Wright-Giemsa, and ATRA-treated HL-60 cells
were stained with Giemsa. Scale bar, 100 mm. (B, C) Analysis of enzyme expression during macrophage- (B) and neutrophil differentiation (C) of HL-60
cells. CD11b was used as a marker of myeloid differentiation. Cont indicates a positive control used as follows; skeletal muscle was used for AK2,
CKMT1 and CKMT2 in B and for CKMT1 and CKMT2 in C, and kidney was used for AK2 in C.
doi:10.1371/journal.pone.0089916.g004
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Figure 5. Effects of AK2 knockdown on macrophage- and neutrophil differentiation of HL-60 cells. (A) Effects of AK2 knockdown on
macrophage- and neutrophil differentiation; N, control siRNA treatment; CD11b, differentiation marker; cont, mouse heart (AK2, CKMT1 and 2),
human leukocyte (CD11b). (B) Rates of myeloid differentiation were assessed using NBT assays. Differentiated macrophage- and neutrophil HL-60
cells are NBT positive. N, control siRNA treatment; ** p,0.01. Experiments were performed in triplicate. (C) ROS measurement in HL-60 cells during
macrophage- and neutrophil differentiations. Relative ratio of fluorescent intensity correlated to ROS production during myeloid differentiations was
assessed at the each time point of the upper time course. Negative control siRNA treated samples, N = 3; AK2 siRNA treated samples, N = 4. * p,0.05.
doi:10.1371/journal.pone.0089916.g005
AK2 in Neutrophil Differentiation
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Figure 6. Working hypothesis for the role of AK2 during hematopoietic differentiation of bipotent HL-60 progenitor cells. Human
AK2-deficient hematopoietic progenitor cells can differentiate into macrophages but not into neutrophils (upper panel). During differentiation into
macrophages (left panel), CKMT1 may interact with mitochondrial ATP synthase, ANT, and voltage-dependent anion channel (VDAC). This interaction
recycles ATP-ADP in IMS without AK2. ATP from CKMT1-mediated ADP recycling could be used for cellular function including UPR to decrease ER
stress induced by de novo neosynthesized proteins and to support macrophage differentiation. During neutrophil differentiation (right panel), AK2-
deficient hematopoietic progenitor cells could not fully maintain mitochondrial adenine nucleotide homeostasis. The subsequent ER and oxidative
stresses may impair differentiation and cellular functions. Disturbed adenine nucleotide metabolism in IMS may lead to ER stress and abnormal ROS
production as shown in patients with RD and our AK2- deficient experimental models resulting in either neutropenia or impairment of neutrophil
differentiation. IM and OM indicate mitochondrial inner and outer membranes, respectively. Open arrows and dotted-lines indicate the possible
regulations, filled allows are the confirmed findings in this study.
doi:10.1371/journal.pone.0089916.g006
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mitochondrial adenine nucleotide metabolizing enzymes such as
AK2, CKMT1 and CKMT2 in IMS, may result in impairment of
ADP recycling, which weakens mitochondrial ATP production.
Subsequently, mitochondrial dysfunction may trigger (1) uncon-
trolled leakage of electrons from the electron transfer chain and
ATP deficit, and (2) impairment of unfolded protein response
(UPR) to the increasing demand for protein production during
somatic cell differentiation. Finally, reactive oxygen species and
ER stress may be increased [38]–[40]. In agreement with this
model, it was recently reported that AK2 is important for UPR
activity in ER during adipocyte and B cell differentiation [21]. It is
not unclear how AK2 knockdown affects neutrophil differentiation.
As one of possible mechanisms, Burkart et al reported that AK2
deficiency blocks adipocyte differentiation directly through UPR
and/or ER stress [21]. Therefore, we also examined the levels of
IRE1 and sXBP1 expression and found that they were decreased
by AK2 knockdown in a HL-60 model of neutrophil differentiation
(data not shown), suggesting that AK2 deficiency might be linked
with ER stress during neutrophil differentiation. However, further
investigation is required for better understanding the relationship
between ADP recycling across IMS and ER stress including UPR.
In addition, under physiological conditions, ROS production in
mitochondria plays important roles in cellular differentiation and
cell signaling [41], [42]. However, excessive ROS production
under pathological conditions such as ischemia and mitochondrial
membrane depolarization is detrimental to cellular function [43].
In our study, AK2-knockdown treatment specifically enhanced
ROS production in ATRA-induced neutrophil differentiated HL-
60 cells (Figure 5C). Moreover, in Ant1-deficient mouse as a
disruption model of oxidative phosphorylation, it was reported
that blocking of ATP and ADP exchange across the mitochondrial
inner membrane resulted in high levels of ROS production [44].
When matrix ADP is not enough supplied, ATP synthase is no
more able to synthesize ATP because of substrate deficiency,
causing uncoupling with respiration in mitochondria. Thereby,
inhibition of the ATP synthase by impairment of ADP recycling
may affect the electrochemical gradient, ROS production from
Complexes I and III of the mitochondrial electron transfer chain
[45], and impairment of mitochondrial membrane potential [46].
However, activation of oxidative phosphorylation by recycled
ADP would increase respiratory rates and decrease mitochondrial
membrane potential and ROS production [46]. In agreement with
this scenario, creatine limitation enhanced ROS production in rat
brains and embryonic cortical neurons, wherein only Ckmt1 is
expressed as an ADP recycler of IMS, indicating that ADP
recycling by Ckmt1 prevents intracellular ROS generation [40]. In
addition, it was demonstrated that yeast mitochondrial AK located
close to ANT functions to supply ADP to ATP synthase in matrix,
whereas disruption of mitochondrial AK would prevent ANT from
ATP export in exchange for ADP [47]. These findings suggest that
defects of mitochondrial adenine nucleotide metabolizing kinases
may lead to proton accumulation, hyperpolarization, and exces-
sive ROS production resulting from impairment of ATP-ADP
recycling. Therefore, AK2 may play the critical roles to maintain
mitochondrial ADP and ATP levels, control ROS production, and
regulate cell-fate. AK2 has been reported to be released during
apoptosis [48] and to form a complex with FADD and caspase-10
and involved the decision of cell death or alive [49]. Further
detailed investigation is required for understanding the relation-
ship among ATP synthesis, H+ generation, and ROS production
including apoptosis.
In conclusion, we found that mitochondrial adenine nucleotide
metabolizing enzymes Ak2, Ckmt1, Ckmt2, and Ndpk-d were
differentially regulated according to tissue types and differentiation
stages. Exclusive expression of AK2 during neutrophil differenti-
ation may link AK2 deficiency and impairment of neutrophil
differentiation as a possible causative mechanism of RD. Further
studies are required to confirm the regulatory role of AK2 in
physiological hematopoiesis and to develop corresponding thera-
peutic strategies for RD.
Supporting Information
Figure S1 AK2 isoform-expressions in adult mouse
tissues, ES cells, E8 embryos and HL-60 cells. (A) Primer
designs for human AK2 isoforms and mouse Ak2 isoforms. Arrows
indicate isoform-specific primers of each species. The following
primers were used; Ak2AB forward 59-CTGTTGGAGT-
GAAGCTTTGG-39, Ak2A reverse 59-CTAACCATCACCACC-
CACTC-39, Ak2B reverse 59-GCACCTAAGAGCAGGGATCC-
39, AK2AB forward 59-GTGGCAGTGAGAGACTTCGG-39,
AK2A reverse 59-CCTATCATTCCCACCCATTG-39, AK2B
reverse 59-GCACCTAAGAGCAGGGATCA-39. (B) Tissue-spe-
cific expression of Ak2A and Ak2B mRNA in adult mouse tissues.
Br, brain; He, Heart; Lu, lung; St, stomach; LI, large intestine; Li,
liver; Ki, kidney; Th, thymus; Sp, spleen; BM, bone marrow; Mu,
skeletal muscle; Te, testis. (C) Ak2A and Ak2B mRNA expressions
in mouse ES cells and E8 embryos. ES, mouse ES cells; E8, mouse
E8 embryos. (D) AK2A and AK2B mRNA expressions during 3 sets
of macrophage differentiation by PMA treatment and 2 sets of
neutrophil differentiation by ATRA treatment in human HL-60
cells. 18S rRNA is presented as a control.
(TIF)
Figure S2 ATP measurement in HL-60 cells during
macrophage- and neutrophil differentiations. ATP
amount was measured using CellTiter-Glo Luminescent Cell
Viability Assay (Promega) according to the manufacturer’s
instruction. Data were shown by relative light units (RLU) of
luciferase activity during myeloid differentiation as shown in ROS
assay (Figure 5C). Open bar; control siRNA treatment (N = 3),
closed bar; AK2 siRNA treatment (N = 4), * p,0.05, ** p,0.01.
(TIF)
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